secwatch.observer — SEC 8-K summary
======================================

Issuer:     American Oncology Network, Inc. (—)
CIK:        0001839998
Form:       8-K
Filed at:   2023-09-26T23:59:59+00:00
Accession:  0001104659-23-103884
Event type: m_and_a
Sentiment:  neutral
Materiality: 1.00
Item codes: 1.01, 2.01, 3.02, 9.01, 3.03, 4.01, 5.01, 5.02, 5.03, 5.05, 5.06, 7.01, 8.01
LLM model:  deepseek-v4-flash:cloud@v2

American Oncology Network completes de-SPAC merger with DTOC; begins trading as AONC
--------------------------------------------------------------------------------

- Business combination closed Sept 20, 2023; DTOC renamed American Oncology Network, Inc. (New AON).
- Post-closing: 9.53M Class A shares and 25.11M Class B shares outstanding; AON equityholders hold ~63.3%.
- AEA Growth received 6.65M Series A preferred shares (8% dividend, convertible after 3 years at $16 trigger).
- Sponsor lock-up for 12 months; 2.92M earnout shares vest at $13.50 VWAP within 5 years.
- Prior to closing, 1.7M DTOC shares redeemed at ~$10.50 per share.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1839998/000110465923103884/0001104659-23-103884-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1839998/000110465923103884/tm2326791d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-103884

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer